EF
NVCR icon

Empowered Funds’s NovoCure NVCR Stock Holding History

Empowered Funds’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.5M Buy
+1,154,431
New +$17.5M 0.09% 230
2021
Q4 		– Sell
-12,741
Closed -$1.48M – 278
2021
Q3 		$1.48M Buy
12,741
+3,237
+34% +$489K 0.19% 128
2021
Q2 		$2.11M Buy
+9,504
New +$1.85M 0.27% 96
2020
Q2 		– Sell
-13,840
Closed -$1.17M – 139
2020
Q1 		$1.17M Hold
13,840
– – 0.42% 96
2019
Q4 		$1.17M Buy
13,840
+707
+5% +$57.1K 0.42% 96
2019
Q3 		$982K Sell
13,133
-7,803
-37% -$624K 0.43% 86
2019
Q2 		$1.32M Sell
20,936
-6,455
-24% -$327K 0.55% 51
2019
Q1 		$1.32M Buy
+27,391
New +$1.32M 0.47% 90

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Empowered Funds's NVCR Position: Q2 2026 in Review

Empowered Funds opened a new position in NovoCure (NVCR) in Q2 2026: 1,154,431 shares worth $17.5M. The stake represents 0.09% of the portfolio and ranks #230 among its holdings. This is a return to the name: Empowered Funds previously reported a position in NVCR as recently as Q3 2021.

Empowered Funds first reported a position in NVCR in Q1 2019 and has held it in 8 quarters since. 218 funds tracked by Wall St. Rank hold NVCR as of Q2 2026.

  • Empowered Funds held 1,154,431 shares of NovoCure worth $17.5M as of Q2 2026.
  • NovoCure was a new Empowered Funds position in Q2 2026.
  • NovoCure made up 0.09% of Empowered Funds's portfolio in Q2 2026, its #230 holding.
  • Empowered Funds first reported a position in NovoCure in Q1 2019 and has held it in 8 quarters since.
  • 218 funds tracked by Wall St. Rank held NovoCure as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.